Method and apparatus for transapical procedures on a mitral valve

Information

  • Patent Grant
  • 10639024
  • Patent Number
    10,639,024
  • Date Filed
    Friday, May 26, 2017
    7 years ago
  • Date Issued
    Tuesday, May 5, 2020
    4 years ago
Abstract
Apparatus and methods for performing a non-invasive procedure to repair a cardiac valve are described herein. In some embodiments, apparatus and methods are described herein for repairing a mitral valve using an edge-to-edge repair to secure the mitral valve leaflets. Implant securing devices are also described that can be used during a procedure to repair a mitral valve. In some embodiments, an implant securing device includes an outer member and an inner member movably disposed within the outer member. The inner member can be used to hold or secure a suture extending from an implant deployed on an atrial side of a leaflet of a mitral valve, and the outer member can be used to push or move a half hitch knot toward a ventricular side of the leaflet, which can be used to secure the implant in the desired position.
Description
BACKGROUND

Some embodiments described herein relate to methods and apparatus for performing cardiac valve repairs, and more particularly, methods and apparatus for performing minimally invasive mitral or tricuspid valve repairs.


Various disease processes can impair the proper functioning of one or more of the valves of the heart. These disease processes include degenerative processes (e.g., Barlow's Disease, fibroelastic deficiency), inflammatory processes (e.g., Rheumatic Heart Disease), and infectious processes (e.g., endocarditis). Additionally, damage to the ventricle from prior heart attacks (i.e., myocardial infarction secondary to coronary artery disease) or other heart diseases (e.g., cardiomyopathy) can distort the valve's geometry causing it to dysfunction.


Mitral valve regurgitation occurs when the leaflets of the valve do not close completely thereby causing blood to leak back into the prior chamber. There are three mechanisms by which a valve becomes regurgitant or incompetent. The three mechanisms include Carpentier's type I, type II and type III malfunctions. A Carpentier type I malfunction involves the dilation of the annulus such that normally functioning leaflets are distracted from each other and fail to form a tight seal (i.e., do not coapt properly). Included in a type I mechanism malfunction are perforations of the valve leaflets, as in endocarditis. A Carpentier's type II malfunction involves prolapse of one or both leaflets above the plane of coaptation. This is the most common cause of mitral regurgitation, and is often caused by the stretching or rupturing of chordae tendineae normally connected to the leaflet. A Carpentier's type III malfunction involves restriction of the motion of one or more leaflets such that the leaflets are abnormally constrained below the level of the plane of the annulus. Leaflet restriction can be caused by rheumatic disease (IIIa) or dilation of the ventricle (IIIb).


Mitral valve disease is the most common valvular heart disorder, with nearly 4 million Americans estimated to have moderate to severe mitral valve regurgitation (“MR”). MR results in a volume overload on the left ventricle which in turn progresses to ventricular dilation, decreased ejection performance, pulmonary hypertension, symptomatic congestive heart failure, atrial fibrillation, right ventricular dysfunction and death. Successful surgical mitral valve repair restores mitral valve competence, abolishes the volume overload on the left ventricle, improves symptom status and prevents adverse left ventricular remodeling.


Malfunctioning valves may either be repaired or replaced. Repair typically involves the preservation and correction of the patient's own valve. Replacement typically involves replacing the patient's malfunctioning valve with a biological or mechanical substitute. Typically, replacement is preferred for stenotic damage sustained by the leaflets because the stenosis is irreversible. The mitral valve and tricuspid valve, on the other hand, are more prone to deformation. Deformation of the leaflets, as described above, prevents the valves from closing properly and allows for regurgitation or back flow from the ventricle into the atrium, which results in valvular insufficiency. Deformations in the structure or shape of the mitral valve or tricuspid valve are often repairable.


In mitral valve regurgitation, repair is preferable to valve replacement. Bioprosthetic valves have limited durability. Moreover, prosthetic valves rarely function as well as the patient's own valves. Additionally, there is an increased rate of survival and a decreased mortality rate and incidence of endocarditis for repair procedures. Further, because of the risk of thromboembolism, mechanical valves often require further maintenance, such as the lifelong treatment with blood thinners and anticoagulants. Therefore, an improperly functioning mitral valve or tricuspid valve is ideally repaired, rather than replaced. However, because of the complex and technical demands of the repair procedures, the mitral valve is still replaced in approximately one third of all mitral valve operations performed in the United States.


Carpentier type I malfunction, sometimes referred to as “Functional MR,” is associated with heart failure and affects between 1.6 and 2.8 million people in the United States alone. Studies have shown that mortality doubles in patients with untreated mitral valve regurgitation after myocardial infarction. Unfortunately, there is no gold standard surgical treatment paradigm for functional MR and most functional MR patients are not referred for surgical intervention due to the significant morbidity, risk of complications and prolonged disability associated with cardiac surgery. Surgeons use a variety of approaches ranging from valve replacement to insertion of an undersized mitral valve annuloplasty ring for patients suffering from functional MR and the long term efficacy is still unclear. Dr. Alfieri has demonstrated the benefit of securing the midpoint of both leaflets together creating a double orifice valve in patients with MR known as an “Edge-to-Edge” repair or an Alfieri procedure.


Regardless of whether a replacement or repair procedure is being performed, conventional approaches for replacing or repairing cardiac valves are typically invasive open-heart surgical procedures, such as sternotomy or thoracotomy, which require opening up of the thoracic cavity so as to gain access to the heart. Once the chest has been opened, the heart is bypassed and stopped. Cardiopulmonary bypass is typically established by inserting cannulae into the superior and inferior vena cavae (for venous drainage) and the ascending aorta (for arterial perfusion), and connecting the cannulae to a heart-lung machine, which functions to oxygenate the venous blood and pump it into the arterial circulation, thereby bypassing the heart. Once cardiopulmonary bypass has been achieved, cardiac standstill is established by clamping the aorta and delivering a “cardioplegia” solution into the aortic root and then into the coronary circulation, which stops the heart from beating. Once cardiac standstill has been achieved, the surgical procedure may be performed. These procedures, however, adversely affect almost all of the organ systems of the body and may lead to complications, such as strokes, myocardial “stunning” or damage, respiratory failure, kidney failure, bleeding, generalized inflammation, and death. The risk of these complications is directly related to the amount of time the heart is stopped (“cross-clamp time”) and the amount of time the subject is on the heart-lung machine (“pump time”).


Thus there is a significant need to perform mitral valve repairs using less invasive procedures while the heart is still beating. Accordingly, there is a continuing need for new procedures and devices for performing cardiac valve repairs, such as mitral valve repair, which are less invasive, do not require cardiac arrest, and are less labor-intensive and technically challenging.


SUMMARY

Apparatus and methods for performing a non-invasive procedure to repair a cardiac valve are described herein. In some embodiments, apparatus and methods are described herein for repairing a mitral valve using an edge-to-edge procedure (also referred to as an Alfieri procedure) to secure the mitral valve leaflets. Implant securing devices are also described that can be used during a procedure to repair a mitral valve. In some embodiments, an implant securing device includes an outer member and an inner member movably disposed within the outer member. The inner member can be used to hold or secure a suture extending from an implant deployed on an atrial side of a leaflet of a mitral valve, and the outer member can be used to push or move a knot, such as a half-hitch, toward a ventricular side of the leaflet, which can be used to secure the implant in a desired position.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a top perspective view of a healthy mitral valve with the mitral leaflets closed.



FIG. 2 is a top perspective view of a dysfunctional mitral valve with a visible gap between the mitral leaflets.



FIG. 3 is a schematic illustration of a side perspective view of a mitral valve with implants, according to an embodiment.



FIG. 4 is a side view of a portion of a knot pusher device, according to an embodiment.



FIG. 5 is a schematic illustration of a side perspective view of the mitral valve of FIG. 3, shown with a portion of the knot pusher device of FIG. 4 in a first position of a procedure to repair a mitral valve.



FIG. 6 is a schematic illustration of a bottom perspective view of the mitral valve of FIG. 3, shown with a portion of the knot pusher device of FIG. 4 in a second position of a procedure to repair a mitral valve.



FIG. 7 is a schematic illustration of a bottom perspective view of the mitral valve of FIG. 3, shown with a portion of the knot pusher device of FIG. 4 in a third position of a procedure to repair a mitral valve.



FIG. 8 is a schematic illustration of a bottom perspective view of the mitral valve of FIG. 3, shown with a portion of the knot pusher device of FIG. 4 in a fourth position of a procedure to repair a mitral valve.



FIG. 9 is a schematic illustration of a bottom perspective view of the mitral valve of FIG. 3, shown with a portion of the knot pusher device of FIG. 4 in a fifth position of a procedure to repair a mitral valve.



FIG. 10 is a schematic illustration of a bottom perspective view of the mitral valve of FIG. 3, shown with a portion of the knot pusher device of FIG. 4 in a sixth position of a procedure to repair a mitral valve.



FIG. 11 is a schematic illustration of a bottom perspective view of the mitral valve of FIG. 3, shown with a portion of the knot pusher device of FIG. 4 in a seventh position of a procedure to repair a mitral valve.



FIG. 12 is a schematic illustration of a bottom perspective view of the mitral valve of FIG. 3, shown after the knot pusher device of FIG. 4 has been removed from the implants, i.e. in an eighth position of a procedure to repair a mitral valve.



FIG. 13 is a side view of a portion of a pusher device, according to another embodiment.



FIG. 14 is a side view of a portion of a pusher device, according to yet another embodiment.



FIG. 15 is a schematic illustration of a side perspective view of the mitral valve of FIG. 3, illustrating a collar coupled to the suture portions, according to an embodiment.



FIG. 16 is a schematic illustration of a side perspective view of the mitral valve of FIG. 3, illustrating a collar coupled to the suture portions, according to another embodiment.





DETAILED DESCRIPTION

Apparatus and methods for performing a non-invasive procedure to repair a cardiac valve are described herein. In some embodiments, apparatus and methods are described herein for performing a non-invasive procedure for repairing a mitral valve using an edge-to-edge stitch (also referred to as an Alfieri procedure) to secure an implant to the mitral valve leaflets.


As illustrated in FIG. 1, the mitral valve 22 includes two leaflets, the anterior leaflet 52 and the posterior leaflet 54, and a diaphanous incomplete ring around the valve, called the annulus 53. The mitral valve 22 has two papillary muscles, the anteromedial and the posterolateral papillary muscles (not shown), which attach the leaflets 52, 54 to the walls of the left ventricle (not shown) via the chordae tendineae (not shown). The mitral valve 22, also referred to as the left atrioventricular valve, controls the passage of oxygenated blood from the left atrium (not shown) of the heart to the left ventricle (not shown). The mitral valve 22 is part of the “left” heart, which controls the flow of oxygen-rich blood from the lungs to the body. The mitral valve 22 lies between a receiving chamber (atrium) and a ventricle so as to control the flow of blood from the atria to the ventricles and prevent blood from leaking back into the atrium during ejection into the ventricle.



FIG. 2 illustrates a prolapsed mitral valve 22. As can be seen with reference to FIG. 2, prolapse occurs when a leaflet 52, 54 of the mitral valve 22 is displaced into the left atrium (not shown) during systole. Because one or more of the leaflets 52, 54 malfunction, the mitral valve 22 does not close properly, and, therefore, the leaflets 52, 54 fail to coapt. This failure to coapt causes a gap 63 between the leaflets 52, 54 that allows blood to flow back into the left atrium, during systole, while it is being ejected into the left ventricle. As set forth above, there are several different ways a leaflet may malfunction, which can thereby lead to regurgitation.


Mitral valve regurgitation increases the workload on the heart and may lead to very serious conditions if left un-treated, such as endocarditis, congestive heart failure, permanent heart damage, cardiac arrest, and ultimately death. Since the left heart is primarily responsible for circulating the flow of blood throughout the body, malfunction of the mitral valve 22 is particularly problematic and often life threatening.


As described in detail in PCT International Application No. PCT/US2012/043761 (published as WO 2013/003228 A1) (referred to herein as “the '761 PCT Application), the entire disclosure of which is incorporated herein by reference, methods and devices are provided for performing non-invasive procedures to repair a cardiac valve, such as a mitral valve. Such procedures include procedures to repair regurgitation that occurs when the leaflets of the mitral valve do not coapt at peak contraction pressures, resulting in an undesired back flow of blood from the ventricle into the atrium. As described in the '761 PCT Application, after the malfunctioning cardiac valve has been assessed and the source of the malfunction verified, a corrective procedure can be performed. Various procedures can be performed in accordance with the methods described therein to effectuate a cardiac valve repair, which will depend on the specific abnormality and the tissues involved.


In some embodiments, a method includes the implantation of one or more artificial chordae tendineae into one or more leaflets of a malfunctioning mitral valve 22 and/or tricuspid valve. It is to be noted that, although the following procedures are described with reference to repairing a cardiac mitral valve by the implantation of one or more artificial chordae, the methods presented are readily adaptable for various types of leaflet repair procedures. In general, the methods herein will be described with reference to a mitral valve 22.



FIGS. 3-12 illustrate a method and device for securing an artificial tendineae that has been implanted as described in the '761 PCT Application. FIG. 3 is a schematic illustration of a mitral valve 122 with leaflets 152, 154 that are separated by a gap 163. As shown in FIG. 3, two bulky knot implants 131, 131′ are disposed on an atrial, distal, or top side of the leaflets 152, 154, respectively. The implants 131, 131′ can be formed with a suture material that forms a loop on the atrial side of the leaflets 152, 154 and extends through the leaflets 152, 154, with two loose suture end portions that extend on the ventricular, proximal, or bottom side of the leaflets 152, 154. The implant 131 has suture end portions 132 and 133, and the implant 131′ has suture end portions 134 and 135 (not shown in FIG. 3; see FIG. 5).


After the implants 131, 131′ are in a desired position, for example, as confirmed with imaging, a securing device 140 as shown in FIG. 4 can be used during a procedure to secure the implants 131, 131′ in the desired position and to secure the valve leaflets 152, 154 in an edge-to-edge relationship. For example, the implants 131, 131′ can be secured together to decrease the septal-lateral distance of the mitral valve annulus. The securing device 140 includes an outer member 144 and an inner member 146 movably disposed within a lumen of the outer member 144. The outer member 144 defines a side window 150 through which a portion of a suture can be disposed as described in more detail below. The inner member 146 defines a lumen 145 and includes a stop member 148. The stop member 148 can be used to limit the movement of the outer tubular member 144 along the length of the inner member 146. The lumen 145 can receive one or more suture portions as described in more detail below.


The inner member 146 can be used to hold a suture portion extending from the knot implant 131 and a suture portion extending from the knot implant 131′. For example, FIG. 4 illustrates the suture portion 133 from implant 131 and the suture portion 134 from implant 131′ extending through the lumen 145. The outer member 144 can be used to tie knots in the other two free end suture portions, for example, the suture portion 132 from implant 131 and suture portion 135 from implant 131′. Although not shown, the inner member 146 can also include a clamp portion or member that can be used to clamp or hold the suture portions during the procedure.


During a procedure to repair a mitral valve, the suture portion 133 of the implant 131 and the suture portion 134 of the implant 131′ are threaded through the lumen 145 of the inner member 146 as shown in FIGS. 4 and 5. The two other free end suture portions 132 and 135 extend along an outer portion of the outer member 144. The inner member 146 can be moved relative to the outer member 144 distally toward the leaflets 152, 154 until a distal end of the inner member 146 contacts the bottom side of the leaflets 152, 154 (or any other position the operator deems appropriate) and can clamp or maintain the sutures temporarily in place, such as by applying and maintaining tension on the sutures to minimize the force that the moving leaflets 152, 154 exert on the two other free end suture portions 132 and 135. The suture portion 135 can be threaded through a distal opening of the outer member 144 and through the side window 150 as shown in FIG. 6. A half hitch knot 155 can then be formed with the suture portion 132 and the suture portion 135 distal of the distal end of the outer member 144, as shown in FIG. 7.


After the half hitch knot has been formed, the outer member 144 can be moved distally to push the half hitch knot 155 distally until it contacts or is near the ventricular side of the leaflets 152, 154 as shown in 8. This process of tying half hitch knots and moving them distally toward the leaflets is repeated until a desired number of knots are formed and a stack or sequence of knots 157 is formed, as shown in FIG. 9. In some embodiments, it may be desirable to have at least two half hitch knots to secure the implants 131, 131′. The movement of the leaflets (during normal functioning) does not affect the knot tying process because the inner member 146 acts as a temporary fixation device. After the desired number of knots have been secured, the securing device 140 can be removed by moving the securing device 140 proximally, as shown in FIG. 9. This releases the hold on the suture portions 133 and 134. Half hitch knots can now be formed with the suture portions 133 and 134.


To form the half hitch knots on the suture portions 133 and 134, the outer member 144 of the securing device 140 can be used, or a separate, single lumen pushing device 160, as shown in FIG. 10, can be used. As shown in FIG. 10, the suture portion 133 can be threaded through a distal end opening defined by the pushing device 160 and then inserted through a side window 162 defined by the pushing device 160. A half hitch knot 156 can then be formed with the suture portion 133 and suture portion 134 as shown in FIG. 10. The pusher device 160 can be moved distally to push the half hitch knot 156 distally toward the bottom side of the leaflets 152, 154, as shown in FIG. 11. As with the suture portions 132 and 135, multiple half hitch knots 156 can be formed with suture portions 133 and 134 and moved distally to form a stack or sequence of knots 159. The pusher device 160 can then be removed.



FIG. 12 illustrates the leaflets 152, 154 and the stack of knots 157 formed with suture portions 132 and 135 and the stack of knots 159 formed with suture portions 133 and 134. Such knots are referred to as an edge-to-edge repair or an Alfieri stitch or procedure. After the desired number of half hitch knots have been formed with all four of the suture end portions 132, 133, 134 and 135, the ends of the sutures can be cut or snipped to a desired length. Alternatively, the distal portion of the suture ends can be secured at or near the apex of the left ventricle to add a downward force on the stack of knots 157, 159 as described in more detail below.



FIGS. 13 and 14 each illustrate a different embodiment of a pusher device that can be used in a mitral valve repair procedure as described herein. The pusher device 260 shown in FIG. 13 is a single knot pusher device and pusher device 360 shown in FIG. 14 is a double knot pusher device. Pusher device 260 includes a prong 264 and the pusher device 360 includes two prongs 364. Each of the pusher devices 260 and 360 can be used to push a half hitch knot distally toward the bottom side of the mitral valve leaflets. The pusher device 360 can be used to push two half hitch knots simultaneously. For example, the pusher devices 260, 360 can be used in conjunction with another device that can be used to hold two free end portions of suture extending from an implant such as the implants 131, 131′. A half hitch knot can be formed with the other two free end portions of suture and the pusher device 260 or 360 can be used to push the half hitch knot distally to a desired position below the leaflets of the valve. For example, the prong 264 of the pusher device 260 can push the half hitch knot distally. With the pusher device 360, two half hitch knots can be formed and the two prongs 364 can each be used to push one of the half hitch knots distally to the desired position. When in the desired position, the prongs 364 can be removed from the half hitch knots and the two half hitch knots can be tightened onto one another before pushing additional half hitch knots to the initial stack of two knots. Either of these pusher devices can be used in conjunction with any suitable device or technique to approximate and maintain the edges of the valve leaflets while the first two or more knots, e.g. half hitches, are moved to the desired position adjacent the ventricular side of the leaflets using the pusher device. For example, a tube such as the inner member 146 of the securing device 140 can be used. Alternatively, rapid pacing of the heart can be used to minimize the relative motion of the edges of the valve leaflets while knots are placed and secured. Once a suture portion from each of at least one implant on each leaflet have been knotted together, the leaflets are secure in the desired edge-to-edge relationship, and additional suture portions of the same, and/or additional, implants can be knotted together.


In some embodiments, in addition to securing the mitral valve implants (e.g., 131, 131′) with half hitch knots, or alternatively, it may be desirable to include a holding member to anchor the free, proximal ends of the suture portions. Examples of such anchoring devices are shown and described in the '761 PCT Application with reference to FIG. 21. There, the suture ends are anchored outside the apex of the ventricle by tying knots or using a pledget as shown in FIG. 21.


In another embodiment, after implanting one or more bulky knot implants in each mitral valve leaflet, the terminal ends of all of the suture portions can be drawn through a tubular collar 442, as shown in FIG. 15. Tubular collar 442 may be formed of any suitable material such as ePTFE. The terminal ends can be drawn into and through the tubular collar 442 using any suitable technique, such as inserting a conventional suture threading device with an eyelet at its distal end through the tubular collar 442, capturing the terminal ends, and then withdrawing the suture threader and the terminal ends proximally through the tubular collar 442. The tubular collar 442 can be disposed in the desired position proximate to the ventricular side of the leaflets, and tension applied to at least one terminal end of each implant, thus approximating the leaflet edges. Tubular collar 442 and terminal ends of the implants can then be secured in position in any of several ways. For example, if the lumen of the tubular collar 442 is sufficiently small in comparison to the perimeter of the bundled terminal ends, knots, e.g. half hitches, can be formed in the terminal ends and pushed up against the proximal end of tubular collar 442, using any of the techniques described above. Alternatively, one or more terminal ends of each implant can be passed distally along the outside of tubular collar 442, then proximally through the lumen of tubular collar 442, and knotted to each other. The remainder of the terminal ends can then be clipped off proximally to the knots, or can be secured to the ventricular apex, as discussed above.


In some embodiments, the suture portions from one of the implants can be threaded through a tubular collar and the suture portions for the other implant can be used to tie half hitches to hold the collar in position. For example, the suture portions 133 and 134 can be threaded through the lumen of the collar 442, and the suture portions 132 and 135 can extend outside the collar 442. A half hitch can then be tied between, for example, suture portion 132 and suture portion 133, and a half hitch can be tied between suture portion 135 and suture 134, to hold the collar in place. In other words, half hitches are tied between a suture portion of one of the implants 131, 131′ and a suture portion of the other of the implants 131, 131′.


In another embodiment, after implanting one or more bulky knot implants in each mitral valve leaflet, the terminal ends of the suture portions of the bulky knot implants can be drawn through a two-lumen collar 542, as shown in FIG. 16. The two-lumen collar 542 can be disposed in the desired position proximate to the ventricular side of the leaflets, and tension applied to at least one terminal end of each implant, thus approximating the leaflet edges. Two-lumen collar 542 and terminal ends of the implants can then be secured in position in any of several ways. For example, a terminal end from each of the two lumens can be knotted together and the knot(s) pushed against the proximal end of the two-lumen collar, e.g. against the land between the two lumens. The remaining terminal ends can be similarly knotted. The terminal ends of the two or more implants in the leaflets can be disposed through the two lumens in any desired combination, e.g. one terminal end of each implant through one lumen, and the other terminal end of each implant through the other lumen, or both terminal ends of one implant through one lumen and both terminal ends of the other (or every other) implant through the other lumen. The remainder of the terminal ends can then be clipped off proximally to the knots, or can be secured to the ventricular apex, as discussed above. Alternatively, the collar can have three or more lumens.


In alternatives to either of the two preceding embodiments, rather than being formed as a collar, the single- or two-lumen device can be formed as an elongate tube that is sufficiently long to extend from the mitral valve to, or through, the ventricular apex, and the tube and terminal ends of the implants can be secured at the apex using any suitable technique.


The above-described procedures can be performed manually, e.g., by a physician, or can alternatively be performed fully or in part with robotic assistance. In addition, although some embodiments described herein include the use of a collar to secure the terminal ends of the suture portions, it should be understood that any of the embodiments described herein can use such a collar in addition to, or alternatively to using half hitch knots. Further, although not specifically described for some embodiments, in various embodiments, the heart may receive rapid pacing to minimize the relative motion of the edges of the valve leaflets while knots are placed and secured.


While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods described above indicate certain events occurring in certain order, the ordering of certain events may be modified. Additionally, certain of the events may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above.


Where schematics and/or embodiments described above indicate certain components arranged in certain orientations or positions, the arrangement of components may be modified. While the embodiments have been particularly shown and described, it will be understood that various changes in form and details may be made. Any portion of the apparatus and/or methods described herein may be combined in any combination, except mutually exclusive combinations. The embodiments described herein can include various combinations and/or sub-combinations of the functions, components and/or features of the different embodiments described.

Claims
  • 1. An apparatus, comprising: an outer member having an axial distal opening, the outer member forming a first lumen and including: a distally-closed side window formed in a distal portion of the outer member; anda distally-open cut-out positioned opposite the distally-closed side window; andan inner member disposed at least partially within the lumen of the outer member, the inner member having an axial distal opening and defining a second lumen configured to receive therethrough a first suture portion extending proximally from a first implant deployed on an atrial side of a first leaflet of a mitral valve and a second suture portion extending proximally from a second implant deployed on an atrial side of a second leaflet of the mitral valve, the inner member including a distal elongate stopper member disposed within the distally-open cut-out of the outer member;wherein the outer member is configured to push distally a knot formed outside of the outer member with a third suture portion extending proximally from the first implant and a fourth suture portion extending proximally from the second implant.
  • 2. The apparatus of claim 1, wherein the side window is configured to receive each of the third suture portion and the fourth suture portion.
  • 3. The apparatus of claim 1, wherein: the first implant is formed integrally with the first suture portion and the third suture portion; andthe second implant is formed integrally with the second suture portion and the fourth suture portion.
  • 4. The apparatus of claim 1, wherein: the first implant is formed at least in part by a first suture forming a first loop on the atrial side of the first leaflet, the first suture portion extending from the first loop and the third suture portion extending from the first loop; andthe second implant is formed at least in part by a second suture forming a second loop on the atrial side of the second leaflet, the second suture portion extending from the second loop and the fourth suture portion extending from the second loop.
  • 5. The apparatus of claim 1, wherein the outer member and the inner member are movable relative to each other between a first position in which a distal end of the outer member is disposed in a first position at a first axial distance from a distal end of the inner member and a second position in which the distal end of the outer member is disposed at a second distance from the distal end of the inner member that is less than the first distance.
  • 6. The apparatus of claim 5, wherein, when the outer member and the inner member are in the first position, at least one of the third suture portion and the fourth suture portion is insertable through the distal opening of the outer member and out through the side window of the outer member.
  • 7. The apparatus of claim 1, wherein the side window is configured to receive one of the first and fourth suture portions.
  • 8. The apparatus of claim 1, wherein a distal end of the inner member is configured to be advanced from within the outer member to contact a ventricular side of each of the first and second leaflets to maintain the first and second suture portions in place.
  • 9. The apparatus of claim 1, wherein the inner member is configured to clamp one or more of the first, second, third, and fourth suture portions.
  • 10. The apparatus of claim 1, wherein the third and fourth suture portions are configured to be formed into a knot outside of the inner and outer members.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 14/584,561, entitled “Method and Apparatus for Transapical Procedures on a Mitral Valve,” filed Dec. 29, 2014, which claims priority to and the benefit from U.S. Provisional Application Ser. No. 61/923,359, entitled “Method and Apparatus for Transapical Procedures on a Mitral Valve,” filed Jan. 3, 2014, each of the disclosures of which is incorporated herein by reference in its entirety.

US Referenced Citations (168)
Number Name Date Kind
3131957 Musto May 1964 A
3752516 Mumma Aug 1973 A
4403797 Ragland, Jr. Sep 1983 A
5144961 Chen et al. Sep 1992 A
5147316 Castillenti Sep 1992 A
5312423 Rosenbluth et al. May 1994 A
5391176 de la Torre Feb 1995 A
5405352 Weston Apr 1995 A
5454821 Harm et al. Oct 1995 A
5472446 de la Torre Dec 1995 A
5507754 Green et al. Apr 1996 A
5527323 Jervis et al. Jun 1996 A
5554184 Machiraju Sep 1996 A
5626614 Hart May 1997 A
5643293 Kogasaka et al. Jul 1997 A
5681331 de la Torre et al. Oct 1997 A
5716368 de la Torre et al. Feb 1998 A
5727569 Benetti et al. Mar 1998 A
5728109 Schulze et al. Mar 1998 A
5746752 Burkhart May 1998 A
5769862 Kammerer et al. Jun 1998 A
5797928 Kogasaka Aug 1998 A
5824065 Gross Oct 1998 A
5931868 Gross Aug 1999 A
5957936 Yoon et al. Sep 1999 A
5971447 Steck, III Oct 1999 A
6010531 Donlon et al. Jan 2000 A
6074417 Peredo Jun 2000 A
6197035 Loubens Mar 2001 B1
6269819 Oz et al. Aug 2001 B1
6332893 Mortier et al. Dec 2001 B1
6562051 Bolduc et al. May 2003 B1
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6840246 Downing Jan 2005 B2
6921408 Sauer Jul 2005 B2
6978176 Lattouf Dec 2005 B2
6991635 Takamoto et al. Jan 2006 B2
6997950 Chawla Feb 2006 B2
7291168 Macoviak et al. Nov 2007 B2
7294148 McCarthy Nov 2007 B2
7309086 Carrier Dec 2007 B2
7316706 Bloom et al. Jan 2008 B2
7373207 Lattouf May 2008 B2
7431692 Zollinger et al. Oct 2008 B2
7513908 Lattouf Apr 2009 B2
7534260 Lattouf May 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7632308 Loulmet Dec 2009 B2
7635386 Gammie Dec 2009 B1
7666196 Miles Feb 2010 B1
7837727 Goetz Nov 2010 B2
7871433 Lattouf Jan 2011 B2
7959650 Kaiser et al. Jun 2011 B2
8029518 Goldfarb et al. Oct 2011 B2
8029565 Lattouf Oct 2011 B2
8043368 Crabtree Oct 2011 B2
8147542 Maisano et al. Apr 2012 B2
8226711 Mortier et al. Jul 2012 B2
8241304 Bachman Aug 2012 B2
8252050 Maisano et al. Aug 2012 B2
8292884 Levine et al. Oct 2012 B2
8303622 Alkhatib Nov 2012 B2
8333788 Maiorino Dec 2012 B2
8382829 Call et al. Feb 2013 B1
8439969 Gillinov et al. May 2013 B2
8454656 Tuval Jun 2013 B2
8475525 Maisano et al. Jul 2013 B2
8500800 Maisano et al. Aug 2013 B2
8608758 Singhatat et al. Dec 2013 B2
8663278 Mabuchi et al. Mar 2014 B2
8771296 Nobles et al. Jul 2014 B2
8828053 Sengun et al. Sep 2014 B2
8852213 Gammie et al. Oct 2014 B2
9131884 Holmes et al. Sep 2015 B2
20020013571 Goldfarb et al. Jan 2002 A1
20030023254 Chiu Jan 2003 A1
20030094180 Benetti May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030120264 Lattouf Jun 2003 A1
20030120341 Shennib et al. Jun 2003 A1
20040044365 Bachman Mar 2004 A1
20040093023 Allen et al. May 2004 A1
20040199183 Oz et al. Oct 2004 A1
20050004667 Swinford et al. Jan 2005 A1
20050075654 Kelleher Apr 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050149067 Takemoto et al. Jul 2005 A1
20050149093 Pokorney Jul 2005 A1
20050154402 Sauer et al. Jul 2005 A1
20050216036 Nakao Sep 2005 A1
20050216077 Mathis et al. Sep 2005 A1
20050267493 Schreck et al. Dec 2005 A1
20050277966 Ewers et al. Dec 2005 A1
20060030866 Schreck Feb 2006 A1
20060100698 Lattouf May 2006 A1
20060111739 Staufer May 2006 A1
20060167541 Lattouf Jul 2006 A1
20060190030 To et al. Aug 2006 A1
20060207608 Hirotsuka et al. Sep 2006 A1
20070010857 Sugimoto et al. Jan 2007 A1
20070049952 Weiss Mar 2007 A1
20070112422 Dehdashtian May 2007 A1
20070118151 Davidson May 2007 A1
20070149995 Quinn et al. Jun 2007 A1
20070179530 Tieu Aug 2007 A1
20070197858 Goldfarb et al. Aug 2007 A1
20070213582 Zollinger et al. Sep 2007 A1
20070270793 Lattouf Nov 2007 A1
20080004597 Lattouf et al. Jan 2008 A1
20080009888 Ewers et al. Jan 2008 A1
20080065203 Khalapyan Mar 2008 A1
20080140093 Stone et al. Jun 2008 A1
20080183194 Goldfarb et al. Jul 2008 A1
20080188893 Selvitelli et al. Aug 2008 A1
20080249504 Lattouf et al. Oct 2008 A1
20080269781 Funamura et al. Oct 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090043153 Zollinger et al. Feb 2009 A1
20090105729 Zentgraf Apr 2009 A1
20090105751 Zentgraf Apr 2009 A1
20090276038 Tremulis et al. Nov 2009 A1
20100023056 Johansson et al. Jan 2010 A1
20100023117 Yoganathan et al. Jan 2010 A1
20100023118 Medlock Jan 2010 A1
20100042147 Janovsky et al. Feb 2010 A1
20100174297 Speziali Jul 2010 A1
20100179574 Longoria et al. Jul 2010 A1
20100210899 Schankereli Aug 2010 A1
20100298930 Orlov Nov 2010 A1
20110015476 Franco Jan 2011 A1
20110022083 DiMatteo et al. Jan 2011 A1
20110022084 Sengun et al. Jan 2011 A1
20110028995 Miraki et al. Feb 2011 A1
20110029071 Zlotnick et al. Feb 2011 A1
20110060407 Ketai et al. Mar 2011 A1
20110106106 Meier May 2011 A1
20110144743 Lattouf Jun 2011 A1
20110264208 Duffy et al. Oct 2011 A1
20110270278 Overes et al. Nov 2011 A1
20110288637 De Marchena Nov 2011 A1
20120004669 Overes et al. Jan 2012 A1
20120143215 Carrao et al. Jun 2012 A1
20120150223 Manos et al. Jun 2012 A1
20120179184 Orlov Jul 2012 A1
20120184971 Zentgraf et al. Jul 2012 A1
20120203072 Lattouf et al. Aug 2012 A1
20120226294 Tuval Sep 2012 A1
20120226349 Tuval et al. Sep 2012 A1
20130018459 Maisano et al. Jan 2013 A1
20130035757 Zentgraf et al. Feb 2013 A1
20130197575 Karapetian Aug 2013 A1
20130253641 Lattouf Sep 2013 A1
20130282059 Ketai et al. Oct 2013 A1
20130345749 Sullivan et al. Dec 2013 A1
20140012292 Stewart Jan 2014 A1
20140031926 Kudlik et al. Jan 2014 A1
20140039607 Kovach Feb 2014 A1
20140067052 Chau et al. Mar 2014 A1
20140114404 Gammie et al. Apr 2014 A1
20140214152 Bielefeld Jul 2014 A1
20140243968 Padala Aug 2014 A1
20140364938 Longoria et al. Dec 2014 A1
20150032127 Gammie et al. Jan 2015 A1
20150045879 Longoria et al. Feb 2015 A1
20150250590 Gries et al. Sep 2015 A1
20160345956 Sauer Dec 2016 A1
20170156720 Moehle et al. Jun 2017 A1
Foreign Referenced Citations (14)
Number Date Country
0791330 Jun 2005 EP
WO 1997047246 Dec 1997 WO
WO 2006078694 Jul 2006 WO
WO 2007100268 Sep 2007 WO
WO 2008013869 Jan 2008 WO
WO 2008124110 Oct 2008 WO
WO 2008143740 Nov 2008 WO
WO 2009081396 Jul 2009 WO
WO 2010070649 Jun 2010 WO
WO 2010105046 Sep 2010 WO
WO 2012137208 Oct 2012 WO
WO 2013003228 Jan 2013 WO
WO 2014093861 Jun 2014 WO
WO 2015020816 Feb 2015 WO
Non-Patent Literature Citations (56)
Entry
Office Action for U.S. Appl. No. 11/683,282, dated Feb. 27, 2009, 6 pages.
Neochord, Inc. v. University of Maryland, Baltimore, Case No. IPR2016-00208, Patent Owner's Response Under 37 C.F.R. § 42.120, with Exhibits 1001-1011, filed Sep. 12, 2016, 299 pages.
Neochord, Inc. v. University of Maryland, Baltimore, Case No. IPR2016-00208, Reply to Patent Owner's Response, with Exhibits 1012-1014, filed Nov. 28, 2016, 83 pages.
Supplementary European Search Report for European Application No. 12804880.8, dated Nov. 28, 2014, 6 pages.
Office Action for U.S. Appl. No. 14/138,857, dated May 5, 2014, 12 pages.
Office Action for U.S. Appl. No. 14/478,325, dated Nov. 18, 2014, 9 pages.
Final Office Action for U.S. Appl. No. 14/478,325, dated May 15, 2015, 15 pages.
Office Action for U.S. Appl. No. 14/478,325, dated Mar. 4, 2016, 15 pages.
Final Office Action for U.S. Appl. No. 14/478,325, dated Aug. 17, 2016, 28 pages.
Advisory Action for U.S. Appl. No. 14/478,325, dated Nov. 4, 2016, 4 pages.
Notice of Panel Decision from Pre-Appeal Brief Review for U.S. Appl. No. 14/478,325, mailed Dec. 16, 2016, 2 pages.
International Search Report for International Application No. PCT/US2012/043761, dated Dec. 3, 2012.
International Preliminary Report on Patentability for International Application No. PCT/US2012/043761, dated Jan. 16, 2014.
Office Action for U.S. Appl. No. 14/584,561, dated Oct. 14, 2016, 5 pages.
International Search Report for International Application No. PCT/US2016/055170, dated Jan. 9, 2017, 10 pages.
International Search Report and Written Opinion for International Application No. PCT/US2016/059900, dated Apr. 7, 2017, 11 pages.
Alfieri, O. et al., “The double-orifice technique in mitral valve repair: a simple solution for complex problems,” (2001) J. Thorac. Cardiovasc. Surg., 122(4):674-681.
Barbero-Marcial, M. et al., “Transxiphoid Approach Without Median Sternotomy for the Repair of Atrial Septal Defects,” (1998) Ann. Thorac. Surg., 65(3):771-774.
Braunberger, E. et al., “Very long-term results (more than 20 years) of valve repair with Carpentier's techniques in nonheumatic mitral valve insufficiency,” (2001) Circulation, 104:I-8-I-11.
Carpentier, Alain, “Cardiac valve surgery—the‘French correction’,” The Journal of Thoracic and Cardiovascular Surgery, vol. 86, No. 3, Sep. 1983, 15 pages.
David, T. E. et al., “Replacement of chordae tendineae with Gore-Tex sutures: a ten-year experience,” (1996) J. Heart Valve Dis., 5(4):352-355.
David, T. E. et al., “Mitral valve repair by replacement of chordae tendineae with polytetrafluoroethylene sutures,” (1991) J. Thorac. Cardiovasc. Surg., 101(3):495-501.
Doty, D, B. et al., “Full-Spectrum Cardiac Surgery Through a Minimal Incision: Mini-Sternotomy (Lower Half) Technique,” (1998) Ann. Thorac. Surg., 65(2):573-577.
Duran, C. M. G. et al., “Techniques for ensuring the correct length of new mitral chords,” (2003) J. Heart Valve Dis., 12(2):156-161.
Eishi, K. et al., “Long-term results of artificial chordae implantation in patients with mitral valve prolapse,” (1997) J. Heart Valve Dis., 6(6):594-598.
Frater, R. W. M., “Anatomical rules for the plastic repair of a diseased mitral valve,” (1964) Thorax, 19:458-464.
Frater, R. W. M. et al., “Chordal replacement in mitral valve repair,” (1990) Circulation, 82(suppl. IV):IV-125-IV-130.
Huber, C. H. et al., “Direct Access Valve Replacement (DAVR)—are we entering a new era in cardiac surgery?” (2006) European Journal of Cardio-thoracic Surgery, 29:380-385.
Hvass, U. et al., “Papillary Muscle Sling: A New Functional Approach to Mitral Repair in Patients With Ischemic Left Ventricular Dysfunction and Functional Mitral Regurgitation,” (2003) Ann. Thorac. Surg., 75:809-811.
Kasegawa, H. et al., “Simple method for determining proper length of artificial chordae in mitral valve repair,” (1994) Ann. Thorac. Surg., 57(1):237-239.
Kobayashi, J. et al., “Ten-year experience of chordal replacement with expanded polytetrafluoroethylene in mitral valve repair,” (2000) Circulation, 102(19 Suppl 3):Iii-30-Iii-34.
Kunzelman, K. et al., “Replacement of mitral valve posterior chordae tendineae with expanded polytetrafluoroethylene suture: a finite element study,” (1996) J. Card. Surg., 11(2):136-145.
Langer, F. et al., “RING plus STRING: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation,” (2007) J. Thorac. Cardiovasc. Surg., 133(1): 247-249.
Maisano, F. et al., “The double-orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique,” (2000) European Journal of Cardio-thoracic Surgery, 17(3):201-205.
Merendino, K. A. et al., “The open correction of rheumatic mitral regurgitation and/or stenosis with special reference to regurgitation treated by posteromedial annuloplasty utilizing a pump-oxygenator,” (1959) Annals of Surgery, 150(1):5-22.
Minatoya, K. et al., “Pathologic aspects of polytetrafluoroethylene sutures in human heart,” (1996) Ann. Thorac. Surg., 61(3):883-887.
Mohty, D. et al., “Very long-term survival and durability of mitral valve repair for mitral valve prolapse,” (2001) Circulation, 104:I-1-I-7.
Neochord, Inc. v. University of Maryland, Baltimore, Case No. IPR2016-00208, Petition for Inter PartesReview of U.S. Pat. No. 7,635,386, dated Nov. 18, 2015, 65 pages.
Neochord, Inc. v. University of Maryland, Baltimore, Case No. IPR2016-00208, Declaration of Dr. Lishan Aklog, dated Nov. 17, 2015, 91 pages.
Neochord, Inc. v. University of Maryland, Baltimore, Case No. IPR2016-00208, Decision on Institution of Inter Partes Review,37 CFR §42.108, Paper 6, Entered May 24, 2016, 28 pages.
Nigro, J. J. et al., “Neochordal repair of the posterior mitral leaflet,” (2004) J. Thorac. Cardiovasc. Surg., 127(2):440-447.
Phillips, M. R. et al., “Repair of anterior leaflet mitral valve prolapse: chordal replacement versus chordal shmtening,” (2000) Ann. Thorac. Surg., 69(1):25-29.
Russo, M. J. et al. “Transapical Approach for Mitral Valve Repair during Insertion of a Left Ventricular Assist Device,” Hindawi Publishing Corporation, The Scientific World Journal, vol. 2013, Article ID 925310, [online], Retrieved from the internet: <URL: http://dx.doi.org/10.1155/2013/925310> Apr. 11, 2013, 4 pages.
Sarsam, M. A. I., “Simplified technique for determining the length of artificial chordae in mitral valve repair,” (2002) Ann. Thorac. Surg., 73(5):1659-1660.
Savage, E. B. et al., “Use of mitral valve repair: analysis of contemporary United States experience reported to the society of thoracic surgeons national cardiac database,” (2003) Ann. Thorac. Surg., 75:820-825.
Speziali, G. et al., “Correction of Mitral Valve Regurgitation by Off-Pump, Transapical Placement of Artificial Chordae Tendinae, Results of the European TACT Trial,” AATS 93rd Annual Meeting 2013, www.aats.org, 26 pages.
Suematsu, Y. et al., “Three-dimensional echo-guided beating heart surgery without cardiopulmonary bypass: Atrial septal defect closure in a swine model,” (2005) J. Thorac. Cardiovasc. Surg., 130:1348-1357.
Von Oppell, U. O. et al., “Chordal replacement for both minimally invasive and conventional mitral valve surgery using premeasured Gore-Tex loops,” (2000) Ann. Thorac. Surg., 70(6):2166-2168.
Zussa, C., “Artificial chordae,” (1995) J. Heart Valve Dis., 4(2):S249-S256.
Zussa, C. et al., “Artificial mitral valve chordae: experimental and clinical experience,” (1990) Ann. Thorac. Surg., 50(3):367-373.
Zussa, C. et al., “Seven-year experience with chordal replacement with expanded polytetrafluoroethylene in floppy mitral valve,” (1994) J. Thorac. Cardiovasc. Surg., 108(1):37-41.
Zussa, C. et al., “Surgical technique for artificial mitral chordae implantation,” (1991) Journal of Cardiac Surgery, 6(4):432-438.
Examination Report for European Application No. 12804880.8, dated Jun. 29, 2017, 4 pages.
Examiner's Answer, Patent Trial and Appeal Board, U.S. Appl. No. 14/478,325, dated Jun. 15, 2017, 10 pages.
Banieghbal, B., “Extracorporeal “Giant” Locking Sliding Knot in Pediatric and Neonatal Minimally Invasive Surgery: Indications, Techniques, and Outcomes,” Journal of Laparoendoscopic & Advanced Surgical Techniques, vol. 19, No. 6, 2009, pp. 831-834.
Reul, G. J., Jr., “Use of a new polybutilate-coated polyester suture in cardiovascular surgery,” Cardiovascular Diseases, Bulletin of the Texas Heart Institute, 1977; 4(1): 61-68.
Related Publications (1)
Number Date Country
20170258464 A1 Sep 2017 US
Provisional Applications (1)
Number Date Country
61923359 Jan 2014 US
Divisions (1)
Number Date Country
Parent 14584561 Dec 2014 US
Child 15606510 US